• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-异丁烯酸酯对[甲基-³H]-N-甲基东莨菪碱与毒蕈碱受体结合的亚型选择性抑制作用

Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters.

作者信息

Lysíková M, Fuksová K, Elbert T, Jakubík J, Tucek S

机构信息

Institute of Physiology, Academy of Sciences of the Czech Republic, Prague.

出版信息

Br J Pharmacol. 1999 Jul;127(5):1240-6. doi: 10.1038/sj.bjp.0702646.

DOI:10.1038/sj.bjp.0702646
PMID:10455271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1566119/
Abstract

Seven esters of alpha-truxillic acid have been synthesized: bis-3-piperidylpropyl ester and its quaternary bis-N-ethyl derivative, bis-N-diethylaminopropyl ester and its quaternary bis-N-methyl derivative, and bis-4-piperidylbutyl ester and its quaternary bis-N-methyl and bis-N-ethyl derivatives. All esters inhibited the specific binding of muscarinic receptor antagonist [methyl-3H]-N-methylscopolamine ([3H]-NMS) to muscarinic receptors in membranes of CHO cell lines stably expressing the human gene for the M1, M2, M3 or M4 subtype of muscarinic receptors. All esters displayed the highest potency at the M2 and the lowest potency at the M3 receptor subtype. In experiments performed on the M2 muscarinic receptor subtype, the affinity between the receptors and the esters was greatly increased when the concentration of ions was diminished. The highest affinities were found for the tertiary bis-3-piperidylpropyl and bis-4-piperidylbutyl aminoesters (equilibrium dissociation constants of 52 and 179 pM, respectively, in the low ionic strength medium). All investigated esters slowed down the dissociation of [3H]-NMS from the M2 muscarinic receptor subtype. [3H]-NMS dissociation from the M1, M3 and M4 muscarinic receptor subtypes was investigated in experiments with the bis-4-piperidylbutyl aminoester and also found to be decelerated. It is concluded that the esters of alpha-truxillic acid act as M2-selective allosteric modulators of muscarinic receptors and that, by their potency, the tertiary bis-3-piperidylpropyl and bis-4-piperidylbutyl aminoesters surpass the other known allosteric modulators of these receptors.

摘要

已合成了七种α-曲辛二酸酯:双-3-哌啶基丙酯及其季铵双-N-乙基衍生物、双-N-二乙氨基丙酯及其季铵双-N-甲基衍生物、双-4-哌啶基丁酯及其季铵双-N-甲基和双-N-乙基衍生物。所有酯均抑制毒蕈碱受体拮抗剂[甲基-³H]-N-甲基东莨菪碱([³H]-NMS)与稳定表达毒蕈碱受体M1、M2、M3或M4亚型人类基因的CHO细胞系膜中毒蕈碱受体的特异性结合。所有酯在M2受体亚型上显示出最高效力,在M3受体亚型上效力最低。在对M2毒蕈碱受体亚型进行的实验中,当离子浓度降低时,受体与酯之间的亲和力大大增加。叔双-3-哌啶基丙酯和双-4-哌啶基丁酯氨基酯具有最高亲和力(在低离子强度介质中,平衡解离常数分别为52和179 pM)。所有研究的酯均减缓了[³H]-NMS从M2毒蕈碱受体亚型上的解离。在用双-4-哌啶基丁酯氨基酯进行的实验中,还研究了[³H]-NMS从M1、M3和M4毒蕈碱受体亚型上的解离,结果发现其也被减缓。得出的结论是,α-曲辛二酸酯作为毒蕈碱受体的M2选择性变构调节剂,并且就其效力而言,叔双-3-哌啶基丙酯和双-4-哌啶基丁酯氨基酯超过了这些受体的其他已知变构调节剂。

相似文献

1
Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters.α-异丁烯酸酯对[甲基-³H]-N-甲基东莨菪碱与毒蕈碱受体结合的亚型选择性抑制作用
Br J Pharmacol. 1999 Jul;127(5):1240-6. doi: 10.1038/sj.bjp.0702646.
2
Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.阿库氯铵对克隆的M1 - M5毒蕈碱型乙酰胆碱受体正向变构作用的亚型选择性。
J Pharmacol Exp Ther. 1995 Sep;274(3):1077-83.
3
Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors.具有3H-N-甲基东莨菪碱和乙酰胆碱的稠合吲哚环系统的四种立体异构体在M1-M4毒蕈碱受体上的变构效应。
Life Sci. 1999;64(6-7):519-26. doi: 10.1016/s0024-3205(98)00596-7.
4
Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors.氯氮平与毒蕈碱受体M2和M4亚型的相互作用。
Eur J Pharmacol. 1999 Jul 2;376(1-2):119-25. doi: 10.1016/s0014-2999(99)00341-6.
5
Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.M4(m4)毒蕈碱受体亚型的选择性标记与定位
Mol Pharmacol. 1994 Dec;46(6):1028-35.
6
Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.N-[3H]-甲基东莨菪碱独特的动力学结合特性使得在灵长类动物大脑中对M1、M2和M3毒蕈碱受体亚型进行差异标记和定位成为可能。
Synapse. 1993 Aug;14(4):283-96. doi: 10.1002/syn.890140406.
7
Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.从缓冲液依赖性效价变化推导的与游离型及[3H]N-甲基东莨菪碱占据型毒蕈碱M2受体的变构相互作用模式
Naunyn Schmiedebergs Arch Pharmacol. 2000 Dec;362(6):512-9. doi: 10.1007/s002100000316.
8
Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.鱼精蛋白对心脏毒蕈碱受体的复杂变构调节:内源性配体假定模型
Mol Pharmacol. 1992 Aug;42(2):311-21.
9
The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.N-(3-氯丙基)-4-哌啶基二苯基乙酸酯和N-(2-氯乙基)-4-哌啶基二苯基乙酸酯(4-DAMP芥子气)的季铵化转化产物对毒蕈碱受体亚型具有不同的亲和力。
J Pharmacol Exp Ther. 1996 Feb;276(2):405-10.
10
Vinburnine decelerates [3H]N-methylscopolamine binding to recombinant human muscarinic M1-M4 acetylcholine receptors.
Eur J Pharmacol. 2004 Jan 12;483(2-3):229-32. doi: 10.1016/j.ejphar.2003.10.039.

引用本文的文献

1
Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators.分析正构位示踪剂与两种变构调节剂的平衡结合。
PLoS One. 2019 Mar 27;14(3):e0214255. doi: 10.1371/journal.pone.0214255. eCollection 2019.
2
Nickel-Catalyzed Reductive [2+2] Cycloaddition of Alkynes.镍催化炔烃的还原[2+2]环加成反应。
J Am Chem Soc. 2018 Dec 19;140(50):17349-17355. doi: 10.1021/jacs.8b09677. Epub 2018 Dec 10.
3
Allosteric Modulation of Muscarinic Acetylcholine Receptors.毒蕈碱型乙酰胆碱受体的变构调节
Pharmaceuticals (Basel). 2010 Aug 30;3(9):2838-2860. doi: 10.3390/ph3092838.
4
Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists.变构调节剂与4-二甲基氨基吡啶及其他毒蕈碱受体拮抗剂之间的相互作用:拮抗剂分子中氮原子与羧基碳原子之间距离的潜在意义。
Neurochem Res. 2001 Apr;26(4):383-94. doi: 10.1023/a:1010951131496.

本文引用的文献

1
Allosteric interactions at muscarinic cholinoceptors.毒蕈碱型胆碱能受体的变构相互作用。
Clin Exp Pharmacol Physiol. 1998 Mar-Apr;25(3-4):185-94. doi: 10.1111/j.1440-1681.1998.t01-4-.x.
2
Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies.马钱子碱类似物与毒蕈碱受体上的乙酰胆碱之间的亚型选择性正协同相互作用:放射性配体结合研究
Mol Pharmacol. 1998 Mar;53(3):573-89. doi: 10.1124/mol.53.3.573.
3
M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.选择性拮抗剂AF-DX 384与M2受体的结合:共同变构位点的可能参与
Mol Pharmacol. 1998 Feb;53(2):304-12. doi: 10.1124/mol.53.2.304.
4
Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.乙酰胆碱及其他激动剂与变构配体在毒蕈碱型乙酰胆碱受体上的正协同性。
Mol Pharmacol. 1997 Jul;52(1):172-9. doi: 10.1124/mol.52.1.172.
5
Molecular rigidity and potency of bispyridinium type allosteric modulators at muscarinic M2-receptors.双吡啶鎓型变构调节剂对毒蕈碱M2受体的分子刚性和效力
Life Sci. 1997;60(22):1995-2003. doi: 10.1016/s0024-3205(97)00164-1.
6
Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors.
Eur J Pharmacol. 1996 Nov 28;316(1):27-32. doi: 10.1016/s0014-2999(96)00639-5.
7
Search for lead structures to develop new allosteric modulators of muscarinic receptors.
J Pharmacol Exp Ther. 1996 Nov;279(2):926-33.
8
Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.阿库氯铵对心脏毒蕈碱型乙酰胆碱受体的空间位阻及协同作用机制。
Mol Pharmacol. 1994 Apr;45(4):709-17.
9
Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors.鉴定与d - 筒箭毒碱竞争心肌毒蕈碱受体变构位点的药物。
Mol Pharmacol. 1994 Oct;46(4):685-92.
10
Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium.
J Neurochem. 1994 Nov;63(5):1932-40. doi: 10.1046/j.1471-4159.1994.63051932.x.